Cargando…
UPDATE ON FIBROBLAST GROWTH FACTOR 23 IN CHRONIC KIDNEY DISEASE
Chronic kidney disease (CKD) is a public health epidemic that affects millions of people worldwide. Presence of CKD predisposes individuals to high risks of end-stage renal disease, cardiovascular disease and premature death. Disordered phosphate homeostasis with elevated circulating levels of fibro...
Autor principal: | Wolf, Myles |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3434320/ https://www.ncbi.nlm.nih.gov/pubmed/22622492 http://dx.doi.org/10.1038/ki.2012.176 |
Ejemplares similares
-
Lipocalin 2 stimulates bone fibroblast growth factor 23 production in chronic kidney disease
por: Courbon, Guillaume, et al.
Publicado: (2021) -
Fibroblast Growth Factor‐23 Concentration in Dogs with Chronic Kidney Disease
por: Harjes, L.M., et al.
Publicado: (2017) -
Role of fibroblast growth factor 23 in patients with chronic kidney disease
por: Wang, Song-Yan, et al.
Publicado: (2021) -
Fibroblast growth factor 23 is upregulated in the kidney in a chronic kidney disease rat model
por: Sugiura, Hidekazu, et al.
Publicado: (2018) -
Relationship between Fibroblast Growth Factor-23 and Mineral Metabolism in Chronic Kidney Disease
por: Nitta, Kosaku
Publicado: (2010)